Skip to content
drillr.ai
Sign up

300254.SZ

仟源医药

SZSE · Healthcare · C 制造业 · CN

CNY 9.54
+7.43%
Ask drillr

  • Sep 4, 2026, 11:05 UTC

    Qianyuan Pharmaceutical granted 14 million restricted shares to 49 eligible recipients on September 4, 2026, as part of its 2026 restricted stock incentive plan, with an issue price of 6.27 yuan per share.

    Source:

  • Aug 24, 2026, 10:36 UTC

    Qianyuan Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 4.2858 million yuan, up 1,025.28% year-on-year, with revenue of 352 million yuan, down 5.66%.

    Source: